[Gastric emptying in dyspeptic syndromes during treatment with a combination of carbenoxolone and metoclopramide, studied with a meal labeled with 99mTc colloidal sulfate].
D000328:Adult; D000368:Aged; D002229:Carbenoxolone / Q000008:administration & dosage* / Q000627:therapeutic use; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000188:drug therapy*; D005260:Female; D005746:Gastric Emptying; D005756:Gastritis / Q000188:drug therapy*; D005757:Gastritis, Atrophic / Q000188:drug therapy* / Q000503:physiopathology; D005759:Gastroenteritis / Q000188:drug therapy* / Q000503:physiopathology; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000503:physiopathology
D008787:Metoclopramide; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid
Studio dello svuotamento gastrico mediante pasto marcato con 99mTc solfuro colloidale nelle sindromi dispeptiche in corso di trattamento con l'associazione carbenoxolone-metoclopramide.